期刊文献+

冠心病患者血小板表面Fc受体γ链ⅡA和CD40配体的表达

Platelet surface expressions of FcγR Ⅱ A and CD40L in patients with coronary heart disease
下载PDF
导出
摘要 目的研究冠心病患者血小板表面Fc受体γ链ⅡA(FcγRⅡA)和CD40配体(CD40L)的表达水平及其与冠状动脉(冠脉)粥样硬化病变程度的相关性。方法采用流式细胞术检测健康对照组(30名)及冠心病患者(95例)血小板表面FcγRⅡA和CD40L的表达水平,并将冠心病组上述指标与该组患者冠脉造影病变支数Gensini积分进行相关性分析。结果与对照组比较,冠心病组血小板表面FcγRⅡA和CD40L的表达水平叫显升高(P<0.01),血小板FcγRⅡA的表达水平(r_1=0.45,r_2=0.51,r_3=0.57,P<0.05)及CIM01.的表达水平(r_1=0.52,r_2=0.55,r_3=0.63,P<0.05)与冠脉病变支数Gensini积分均呈正相关。结论血小板表面FcγRⅡA和CD40L的表达水平在冠心病患者中升高,可作为评估冠脉病变严重程度的指标。 Objective To observe platelet surface expressions of FcγRⅡA (CD32) and CD40 ligand (CD40L) in patients with coronary heart disease(CHD) and the correlation between two indexes mentioned above and coronary lesion severity. Methods The platelet surface expressions of FcγRⅡA and CIMOL were measured by flow cytometry in 95 patients with CHD and 30 normal controls. The lesion severity of coronary artery was assessed with Gensini coronary scoring system and the correlation was analyzed between the platelet surface expressions of FcγRⅡA and CD40L and coronary lesion severity. Results The platelet surface expressions of FcγRⅡA and CD40L levels in patients with CHD were significantly higher than those in the control group ( both P 〈 0. 01 ), and significant positive correlations were found between the platelet surface expression of FcγRⅡA ( r1 = 0. 45, r2 = 0. 51, r3 = 0. 57, P 〈 0. 05 ) and platelet surface expressions of CD40L ( r1 = O. 52, r2 = O. 55, r3 = 0. 63, P 〈 0. 05) and Gensini coronary scoring system. Conclusions The platelet surface expressions of FcγRⅡA and CD40 elevate in patients with CHD and can be used to assess the severity of coronary artery lesion.
出处 《中国心血管杂志》 2009年第2期123-125,共3页 Chinese Journal of Cardiovascular Medicine
基金 大连市科技局科技计划项目留学回国人员科研基金(2008J22JH016)
关键词 血小板 CD40配体 动脉粥样硬化 Platelet CD40 ligand Atherosclerosis
  • 相关文献

参考文献11

  • 1Poole A, Gibbins JM, Turner M, et al. The Fcy receptor gammachain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J, 1997,16:2555-2541.
  • 2Calverley DC, Brass E, Ilaeker MR, et al. Potential role of platelet FcgarnmaRIIA in collagen-mediated platelet activation associated with atherothrombosis. Atherosclerosis, 2002, 164: 261-267.
  • 3Andre P, Naanizzi-Alaimo L, Prasad SK, et al. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation, 2002,106: 896-899.
  • 4Gensini CG. A more meaningful scoring system for determining the severity of coronary. heart disease. Am J Cardio, 1983, 51 : 606-607.
  • 5I,ibby P,Ridker PM,Maseri A. Inflammation and atherosclerosis. Circulation, 2002,105 : 1135-1143.
  • 6Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost, 2001,86 : 189-197.
  • 7Kalia N, Auger JM, Atkinson B, et al. Critical role of FcR gamma-chain, LAT, PLCgamma2 and thrombin in arteriolar thrombus formation upon mild, laser-induced endothelial injury in vivo. Microcirculation, 2008,15 : 325-335.
  • 8Cabeza N, Li Z, Schulz C, et al. Surface expression of collagen receptor Fc~ receptor-/Glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes, 2004,53:2117-2121.
  • 9Calverley DC, Hacker MR, Loda KA, et al. Increased platelet FeγReeeptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus. Br J Haematol, 2003,121 : 139-142.
  • 10Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci,2001 ,58:443.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部